elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33710967-3C7BF919-659F-45AA-90F9-1ACAF8A20A3C
Q33710967-3C7BF919-659F-45AA-90F9-1ACAF8A20A3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710967-3C7BF919-659F-45AA-90F9-1ACAF8A20A3C
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.
P2860
Q33710967-3C7BF919-659F-45AA-90F9-1ACAF8A20A3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710967-3C7BF919-659F-45AA-90F9-1ACAF8A20A3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e93c7f2b3f8ec10c17678f587497e3719061cbb3
P2860
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.